Takeda Pharmaceutical Company Limited vs Arthur J. Gallagher & Co.
Comparação do valor de mercado ao longo do tempo
Takeda Pharmaceutical Company Limited
$68.4B
Posição #226
Arthur J. Gallagher & Co.
$68.7B
Posição #224
Valor de mercado ao longo do tempo
Momentos-chave
- Arthur J. Gallagher & Co. ultrapassou Takeda Pharmaceutical Company Limited até 2021
Comparação ano a ano
| Ano | Takeda Pharmaceutical Company Limited | Arthur J. Gallagher & Co. | Líder |
|---|---|---|---|
| 2026 | $68.4B | $68.7B | Arthur J. Gallagher & Co. |
| 2025 | $50.3B | $65.9B | Arthur J. Gallagher & Co. |
| 2024 | $41.6B | $71.7B | Arthur J. Gallagher & Co. |
| 2023 | $38.6B | $56.4B | Arthur J. Gallagher & Co. |
| 2022 | $37.6B | $46.7B | Arthur J. Gallagher & Co. |
| 2021 | $27.3B | $41.5B | Arthur J. Gallagher & Co. |
| 2020 | $31.2B | $29.8B | Takeda Pharmaceutical Company Limited |
| 2019 | $34.2B | $22.6B | Takeda Pharmaceutical Company Limited |
| 2018 | $28.0B | $17.1B | Takeda Pharmaceutical Company Limited |
| 2017 | $46.8B | $14.4B | Takeda Pharmaceutical Company Limited |
| 2016 | $34.2B | $11.5B | Takeda Pharmaceutical Company Limited |
| 2015 | $41.4B | $8.7B | Takeda Pharmaceutical Company Limited |
| 2014 | $33.1B | $9.7B | Takeda Pharmaceutical Company Limited |
| 2013 | $30.8B | $9.4B | Takeda Pharmaceutical Company Limited |
| 2012 | $23.7B | $6.8B | Takeda Pharmaceutical Company Limited |
| 2011 | $19.8B | $6.2B | Takeda Pharmaceutical Company Limited |
| 2010 | $22.3B | $5.2B | Takeda Pharmaceutical Company Limited |
| 2009 | $20.5B | $3.8B | Takeda Pharmaceutical Company Limited |
| 2008 | $23.7B | $4.1B | Takeda Pharmaceutical Company Limited |
| 2007 | $32.5B | $3.7B | Takeda Pharmaceutical Company Limited |
| 2006 | $39.6B | $4.3B | Takeda Pharmaceutical Company Limited |
| 2005 | $30.4B | $4.3B | Takeda Pharmaceutical Company Limited |
| 2004 | $24.2B | $4.4B | Takeda Pharmaceutical Company Limited |
| 2003 | $19.6B | $4.2B | Takeda Pharmaceutical Company Limited |
| 2002 | $22.5B | $3.7B | Takeda Pharmaceutical Company Limited |
| 2001 | $26.6B | $4.3B | Takeda Pharmaceutical Company Limited |
| 2000 | $30.0B | $3.9B | Takeda Pharmaceutical Company Limited |